Skip to main content
Premium Trial:

Request an Annual Quote

XDx Files for Review of Source MDx's Gene Expression Monitoring Patent

This article has been updated to include a comment from Source MDx.
NEW YORK (GenomeWeb News) – Molecular diagnostics developer XDx has asked the US Patent and Trademark Office to review a patent for immune system monitoring methods based on gene expression, the company said today. The patent, No. 6,964,850, was originally filed in 2002 and was assigned to the Boulder, Colo.-based company Source MDx.
The ‘850 patent, titled "Identification, Monitoring and Treatment of Disease and Characterization of Biological Condition Using Gene Expression Profiles," makes a claim to “methods for creating an index of a patient’s biological state pertaining to inflammation,” the company said.
XDx said that it has filed the request to have the patent re-examined because it believes prior art references available before the ‘850 patent’s earliest priority date raise “substantial new questions about the patentability of certain of the patent’s claims.”
“We’re totally confident that the patent office is going to stand by the patent,” Karl Wassman, who is CEO of Source MDx, told GenomeWeb Daily News. He added that XDx will have to “prove that there is prior art that the patent office has not seen before,” and he expressed doubt that that is what the patent office will find.

Brisbane, Calif.-based XDx has developed a method for noninvasively monitoring the immune system by measuring gene expression in peripheral blood. The firm said that its technology potentially could help lower healthcare costs associated with a variety of immune-mediated diseases. 


The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.